Evidence-based Dermatology

Contents of the first edition: .

The concept of evidence-based dermatology.

The field and its boundaries.

The rationale for evidence-based dermatology.

The role of the consumer in evidence-based dermatology.

The Cochrane Skin Group.

The critical appraisal toolbox.

Formulating well-built clinical questions.

Finding the best evidence.

The hierarchy of evidence.

How to critically appraise systematic reviews and meta-analyses.

How to assess the evidence for the safety of medical interventions.

How to critically appraise pharmacoeconomic studies.

Applying the evidence back to the patient.

.

The evidence: Common inflammatory skin disease.

Acne vulgaris.

Papulopustular rosacea.

Perioral dermatitis.

Hand eczema.

Atopic eczema.

Seborrhoeic dermatitis.

Psoriasis.

Lichen planus.

Acute urticaria.

.

Skin cancer.

Prevention of skin cancer.

Do sunscreens reduce the incidence of skin cancers?.

Cutaneous melanoma.

Squamous cell carcinoma.

Basal cell carcinoma.

Primary cutaneous T-cell lymphoma.

Actinic keratoses and Bowen's disease.

Kaposi's sarcoma.

.

Infective skin diseases.

Local treatments for cutaneous warts.

Impetigo.

Athlete's foot.

Onychomycosis.

Tinea capitis.

Candidiasis.

Deep fungal infections.

Infestations.

Scabies.

Head lice.

Insect bites.

Vitiligo.

Melasma.

.

Hair Problems.

Male and female androgenetic alopecia.

Alopecia areata.

.

Leg ulceration.

Venous ulcers.

.

Less common skin disorders.

Cutaneous lupus erythematosus.

Dermatomyositis.

Bullous pemphigoid.

Pemphigus.

Cutaneous manifestations of sarcoidosis.

Erythema multiforme.

Stevens-Johnson syndrome and toxic epidermal necrolysis.

Focal hyperhidrosis.

The idiopathic photodermatoses.

.

The future of evidence-based dermatology.

Where do we go from here?

Hywel Williams
Professor of Dermato-Epidemiology,Nottingham UK. Professor Williams is coordinating editor of the Cochrane Skin Group. He is also the dermatology adviser for Clinical Evidence (BMJ Publishing Group) which is distributed to 500 000 doctors in the US, available free to NHS institutions in the UK and is translated into 10 languages.
Michael Bigby
Assistant Professor of Dermatology, Harvard University Medical School and Chief of Dermatology, Harvard University Health Service. His chief teaching interest is in evidence-based dermatology. He edited a special issue of the Archives in Dermatology devoted to ebd, which has resulted in a quarterly ebd section to which he is a continuing contributor, and he has presented papers and chaired sessions on ebd at the AAD. He has played a major part in introducing the concept in the USA.
Thomas Diepgen
Professor of Dematology, University of Heidelberg, Gemany is a member of European Dermato-epidemiology network and a specialist in contact dermatitis, and occupationally and environmentally acquired conditions
Andrew Herxheimer
Cochrane UK Center is a founding member of the Cochrane Collaboration and now a editor of the Consumer and Communications Group. He is part of the Consumer Network and the Adverse Effects Methods subgroup and also works with the Cochrane skin group.
Luigi Naldi
Consultant Dermatologist at Ospedale Riunit Bergamo, Italy and a member of European Dermato-epidemiology network. He specialises in psoriasis.
Berthold Rzany IC3-Professor for Evidence Based Medicine in Dermatology, Head of the division of Evidence Based Medicine at the department of dermatology at the Humboldt-University in Berlin. His research topics include aesthetic medicine (e.g. botulinum toxin A, collagen, hyaluronic acid, polyactic acid & other injectables, middle depth peelings as well as hyperhidrosis